A method is described in which the extent of myocardial infarction in man is assessed by mathematical analysis of the rise in plasma enzyme levels after infarction. Five enzymes are used in this study: lactate dehydrogenase (LDH); alpha-hydroxybutyrate dehydrogenase (a-HBDH); aspartate aminotransferase (GOT); creatine phosphokinase (CPK); and phosphohexoseisomerase (PHI).
method by which tojudge therapeutic effects ofintervention in the course ofa myocardial infarction, as demonstrated in this study by the assessment of the effect of urokinase on the enzyme release after an infarct.
The importance of the determination of serum enzyme levels in patients suspected of an acute myocardial infarction has been well established. Extensive studies have been reported on the clinical usefulness of estimation of serum levels of several enzymes among which GOT, LDH, a-HBDH, and, somewhat more recently, CPK, are used most widely (Dreyfus et However, these studies were mainly of a qualitative nature, used for confirming a diagnosis or for differentiation from other diseases. With the introduction of coronary care units death from myocardial infarction caused by arrhythmias has decreased but power failure still remains an important complication of myocardial infarction. It has been shown that cardiogenic shock after infarction is correlated with large infarcted areas (Harnarayan et al., 1970) .
As more studies become available which show that the extent of the infarcted area in experimental animals can be modified by certain interventions (Ginks et Roberts, I974; Sybers et al., I973) , a quantitative assessment of myocardial infarction in man becomes more and more important as it provides a tool with which the effect of therapeutic regimens in man can be judged.
The concept of using the plasma enzyme increases for quantitative analysis in acute myocardial infarction, as was introduced by our group some years ago (Witteveen, Hermens, and Hemker, I970; Witteveen et al., 197i) , has been developed further and is applied in this study to a group of I5 patients.
The clinical usefulness of the method is shown by comparing a group of 5 patients, who received urokinase, a thrombolytic agent, with a control group of I0 patients. If signs of pulmonary congestion were found on x-ray or physical examination the diuretic frusemide was given. Patients with cardiogenic shock or severe heart failure were not included in the investigation. Anticoagulant therapy was applied in all cases. All patients were given phenprocoumon in the required dosage except Cases I, 2, I0, II, and I2, who received warfarin sodium. The latter group was also given urokinase,' a thrombolytic agent. This drug was administered as soon after admission as possible in an initial loading dose of 7200 CTA units/kg body weight, given over an interval of I0 minutes, after which an infusion of 3600 CTA units/kg body weight per hour was given for i8 hours.
Enzyme determinations
When a patient was admitted to the hospital with a myocardial infarct blood was drawn as soon as possible and thereafter every 4 hours for 2 or 3 days. After that progressively fewer samples were taken until plasma enzyme levels had returned to normal. Each sample con-' Kindly supplied by Hoffman-La Roche, Basle, Switzerland. sisted of I0 ml venous blood collected into tubes containing 0.2 ml 20 per cent sodium citrate solution to prevent clotting. After careful mixing of the blood with the citrate, centrifugation was done at goo g for I0 minutes to remove erythrocytes and leucocytes and subsequently at 40 ooo g for 20 minutes to remove thrombocytes. Thereafter the sample was stored at -200C until determinations were carried out.
Heart tissue was obtained at thoracic surgery on other patients for determination of the enzyme activity in the normal myocardium. Immediately after removal the tissue was placed in isotonic saline at o0C, weighed, and homogenized in a Turrax homogenizer as soon as possible, usually within I0 to I5 minutes. After sedimentation of any remaining particles the enzyme activity in the supematant fluid was determined.
The enzymes determined in this study were aspartate aminotransferase (GOT, E.C.1 2.6.I.I.), lactate dehydrogenase (LDH, E.C. I.I.I.27.), alpha-hydroxybutyrate dehydrogenase (a-HBDH, E.C. I.I.I.27), creatine phosphokinase (CPK E.C. 2.7.3.2.), and phosphohexoseisomerase (PHI, E.C. 5.3.I.9. 
Mathematical analysis of data
Principle After the cessation of blood flow to an area of the myocardium, the tissue in this area dies and releases its enzymes. This release results in a sudden increase in plasma enzyme levels, followed by a gradual decrease to normal values because of diffusion and elimination. If no diffusion occurred from the plasma to an extravascular space, i.e. if the distribution volume equalled the plasma volume, the change in the total amount of enzyme in the plasma at each moment would be a function of influx from the infarcted tissue and of elimination caused by normal biological degradation:
in which Vi is the plasma volume, C, the concentration of enzyme in the plasma, F(t) a function, describing the rate of appearance of enzyme in the plasma, and k the disappearance constant of the enzyme from the plasma.
Once the enzyme stopped, F(t)=0 an release from the infarcted area has id the formula becomes
At This equation has as its solution:
showing an exponential decay of enzyme. Theoretically, by plotting the measured enzyme levels against time on a semilogarithmic scale, starting at a point at which one can be sure that the release of enzyme has stopped (approximately 40 hours after the infarction), it should be possible to determine the elimination constant k. From the curve in which C1 is plotted against time, dCd/dt could be obtained for the period of enzyme release and with k known, the release F(t) could be derived from formula (i).
Another factor -diffusion into an extravascular spacehas to be taken into account. It is known for enzymes as well as for other proteins (Dunn, Martins, and Reissmann, I958; Schultze and Heremans, I966 ) that the protein is not confined to the plasma but that diffusion takes place over a larger volume, representing the plasma volume V1 plus at least one extravascular volume V.. Together these can be viewed as the real distribution volume. The rate of diffusion is proportional to the difference in concentration between the intra-and extra- known that anoxic human heart tissue only loses 8o per cent of its LDH content into the circulation. This means that (Q x V1) has to be multiplied by a factor I.25 to obtain the minimal amount of heart tissue that is infarcted. When (Q xV1 x I.25) is divided by 128 which is the enzyme content in IU per g normal heart tissue (Table 2 ), the equivalent amount in grams of infarcted heart tissue is obtained. For the other enzymes in the study the corresponding value of Q was first transformed into the equivalent value of QLDH, using best fit equations ( Fig. 2) , after which an analogous procedure was followed. LDH was chosen as reference enzyme because it is eliminated slowly and is less sensitive to irregularities in the release.
vascular volumes and to a permeability constant P (Fig. I) .
The balance equations for the exchange of enzyme in this dual compartment model are given by the following equations:
Using these formulae one can in any given patient calculate F(t), the amount of enzyme released per hour. To make this possible, however, V. and P have to be known. By more elaborate mathematical analysis of the data (Witteveen, 1972; (Witteveen, 1972 ; Hermens, to be published), it is Results Table 2 gives the values for the enzyme activity measured in human myocardial tissue, obtained at cardiac surgery. Table 3 gives the characteristics of enzyme levels measured in patients: maximal value, Fig. 3 for GOT. Fig. 3 for PHI.
as described in the methods. Curve 3 shows the rate at which the enzymes were released into the circulation from the necrotic tissue, expressed in IU/litre per hour. Curve 4 shows the total amount of enzyme released into one litre of plasma. The final value in this curve (obtained at 48 hours) is given in Table 4 under column Q. Table 4 ).
Discussion
As can be seen from Table 3 , a wide range of plasma enzyme maxima was found. A maximal plasma level is obtained when enzyme breakdown equals enzyme release. This explains the fact that the time needed to reach a maximal plasma level is proportional to the height of the maximum.
LDH and a-HBDH reach the maximal value later than GOT, PHI, and CPK, i.e. about 36 and 24 hours after the infarction, respectively. This is mainly because of the much higher rate at which GOT, PHI, and CPK disappear from the circulation, as indicated by the disappearance constants which were up to I0 times higher than the values for LDH and a-HBDH. For the latter enzymes, definite rises were often found for more than 2 weeks after the acute attack.
It is clear from our findings that the leakage of enzymes from the cells starts early after the infarction. All patients admitted soon after the onset of acute symptoms already showed some enzyme release 5 hours after the infarction. This holds for all enzymes investigated in this study. From that time on, the amount of enzyme coming into the circulation rose rapidly to reach a maximum between I0 and 20 hours after the moment of infarction (Fig. 8) .
The fact that the rate of release (curve 3, Fig. 3  to 7 ) rises progressively after the initial period and reaches a maximum after I0 to 20 hours reflects the increase in cell membrane permeability resulting from the loss of normal membrane function. As time goes on, the loss of normal membrane structure permits a more rapid diffusion of larger molecules like those forming the enzymes.
Another factor that might explain the low rate of release in the initial phase and the finding of a later maximum is probably that not all cells die and disintegrate at the same moment. Present research in our laboratory (Hermens et al., 1975) indicates that the necrotic process is self-generating in its initial phase. This can be explained by the hypothesis that the cell contents of a disintegrating cell enhance the lysis of neighbouring cells. The decline in the release rate and the finding that no further loss of enzymes occurs after about 48 hours implies that by then the cells have lost their enzymes more or less completely. A remarkable phenomenon was found in patients treated with the thrombolytic agent urokinase. As a group, these patients had an earlier maximal plasma enzyme level, as is shown in Table   5 . The 
